Pacira Biosciences Q1 2026 Results Revenue Beat Exparel Growth and Analyst Expectations European Stocks Poised for Opening Gains as Markets Assess Geopolitical and Economic Signals CCAP Q1 2026 Earnings Slight EPS Miss as Business Development Firm Maintains Steady Performance Billionaire Stanley Druckenmiller Invests 3387 Million in Caris Life Sciences During Q1 Sadiq Khan Blocks 50m Metropolitan Police AI Deal with Palantir Sparking Row AI Biotech Firm Secures 104 Million Investment from Nvidia TGS Q1 2026 Earnings Staggering EPS Beat of 319 Sends Stock Higher POWL Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds